Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference

NEXT STORY
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
PREV STORY
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Threshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO Annual Meeting

CHICAGO, June 06, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced multiple ...

author_avatar
NASDAQ Market News

Welldoc Announces Expansion of Program with Leading Academic Medical Center to Evaluate BlueStar® Digital Therapeutic as a Means of Transforming Population Health in Primary Care

COLUMBIA, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Welldoc® today announced that one of ...

author_avatar
NASDAQ Market News

BioXcel Therapeutics Announces First Patient Enrolled in Phase 1b/2 RELEASE Trial of BXCL501 for the Treatment of Opioid Withdrawal Symptoms

author_avatar
NASDAQ Market News